Sinopharm Vaccine Gets WHO Backing, Facilitating Broader Use
- China-made vaccine will add to supply for Covax global effort
- Questions remain about efficacy compared with other shots
This article is for subscribers only.
China’s Sinopharm Group Co. won World Health Organization backing for its Covid-19 vaccine, paving the way for a wider rollout of the shot in countries scrambling for immunizations.
The WHO listed the vaccine for emergency use, Director General Tedros Adhanom Ghebreyesus said in a tweet on Friday. It’s recommended for adults age 18 and over.